Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children.

The invalid rate for the ID Now assay was significantly lower than that for the LIAT (0.5% versus 5.5%, respectively; P = 0.006) or the Xpert assay (0.5% versus 3%, respectively; P = 0.12), but the difference did not reach statistical significance.

also in 111,027 other papers